ATE322284T1 - Adrenomedullin zur behandlung von störungen des harnlassens - Google Patents
Adrenomedullin zur behandlung von störungen des harnlassensInfo
- Publication number
- ATE322284T1 ATE322284T1 AT00940830T AT00940830T ATE322284T1 AT E322284 T1 ATE322284 T1 AT E322284T1 AT 00940830 T AT00940830 T AT 00940830T AT 00940830 T AT00940830 T AT 00940830T AT E322284 T1 ATE322284 T1 AT E322284T1
- Authority
- AT
- Austria
- Prior art keywords
- adrenomedulline
- treatment
- incontinence
- urination disorder
- adrenomedullin
- Prior art date
Links
- 230000002485 urinary effect Effects 0.000 title 1
- 208000028938 Urination disease Diseases 0.000 abstract 4
- 102000004379 Adrenomedullin Human genes 0.000 abstract 3
- 101800004616 Adrenomedullin Proteins 0.000 abstract 3
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 abstract 3
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000024449 overflow incontinence Diseases 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000011514 reflex Effects 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 206010046494 urge incontinence Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrotherapy Devices (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17754999 | 1999-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE322284T1 true ATE322284T1 (de) | 2006-04-15 |
Family
ID=16032903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00940830T ATE322284T1 (de) | 1999-06-23 | 2000-06-23 | Adrenomedullin zur behandlung von störungen des harnlassens |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6852692B1 (de) |
| EP (1) | EP1205186B1 (de) |
| JP (1) | JP4610142B2 (de) |
| AT (1) | ATE322284T1 (de) |
| DE (1) | DE60027168T2 (de) |
| WO (1) | WO2000078338A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007534611A (ja) * | 2003-04-08 | 2007-11-29 | ジェノバ・リミテッド | 心臓血管障害に関連する分泌ポリペプチド種 |
| JP2007523844A (ja) * | 2003-04-25 | 2007-08-23 | ジェノバ・リミテッド | 心臓血管障害において減少する分泌ポリペプチド種 |
| WO2009104248A1 (ja) | 2008-02-19 | 2009-08-27 | 国立大学法人旭川医科大学 | アドレノメデュリン産生増強剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2774769B2 (ja) * | 1993-04-26 | 1998-07-09 | 賢治 寒川 | アドレノメデュリン |
| ATE265466T1 (de) * | 1994-08-16 | 2004-05-15 | Human Genome Sciences Inc | Calcitoninrezeptor |
| US5888963A (en) * | 1996-04-18 | 1999-03-30 | Auckland Uniservices Limited | Treatment of bone disorders with adrenomedullin |
| WO2001070954A2 (en) * | 2000-03-24 | 2001-09-27 | Bayer Aktiengesellschaft | Regulation of human nerve growth factor-elated g protein-coupled receptor |
-
2000
- 2000-06-23 US US10/018,924 patent/US6852692B1/en not_active Expired - Fee Related
- 2000-06-23 AT AT00940830T patent/ATE322284T1/de not_active IP Right Cessation
- 2000-06-23 WO PCT/JP2000/004166 patent/WO2000078338A1/ja active IP Right Grant
- 2000-06-23 DE DE60027168T patent/DE60027168T2/de not_active Expired - Fee Related
- 2000-06-23 JP JP2001504401A patent/JP4610142B2/ja not_active Expired - Fee Related
- 2000-06-23 EP EP00940830A patent/EP1205186B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4610142B2 (ja) | 2011-01-12 |
| US6852692B1 (en) | 2005-02-08 |
| EP1205186A1 (de) | 2002-05-15 |
| EP1205186A4 (de) | 2003-06-25 |
| EP1205186B1 (de) | 2006-04-05 |
| DE60027168T2 (de) | 2007-01-11 |
| DE60027168D1 (de) | 2006-05-18 |
| WO2000078338A1 (fr) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69833059D1 (de) | Verwendung von Botulinumtoxin zur Behandlung von Harninkontinenz | |
| DE60023043D1 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| MXPA03000436A (es) | Medicamentos que compreden derivados de dicianopiridina. | |
| DE69725484D1 (de) | Vorrichtung zur Behandlung von Harninkontinenz | |
| NO20065380L (no) | Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer. | |
| EP0565616A4 (de) | Verfahren und abnehmbare vorrichtung zum selbst ausgeübten behandeln von infektionen des urintrakts oder anderer erkrankungen und vorrichtung zum gebrauch als harnröhrenpfropfen. | |
| ATE463247T1 (de) | Bupropion metaboliten zur behandlung von angstzuständen | |
| DE69428523D1 (de) | Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind | |
| PL348097A1 (en) | Application of biochemical substances in compositions for preventing occurrence and treating pathogenous states caused by muscular contraction of smooth muscles in body organs | |
| DE69616376D1 (de) | Verwendung von Tiagabin zur Behandlung von Schlafstörungen | |
| ATE437630T1 (de) | Vorrichtung und methode zur behandlung von urininkontinenz bei frauen | |
| DE69210654D1 (de) | Verwendung von Tomoxetine zur Behandlung von Funktionsstörungen der niedrigen Harnwege | |
| HUP0202776A2 (hu) | (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| ATE322284T1 (de) | Adrenomedullin zur behandlung von störungen des harnlassens | |
| DE60022478D1 (de) | Verwendung des vaskularen endothelialen wachstumsfaktors zur behandlung von erektilen dysfunktionen | |
| BR0115882A (pt) | Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária | |
| NO20012569L (no) | Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens | |
| ATE345121T1 (de) | Verwendung von konjugierter linolsäure zur behandlung der erkältung | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| WO2002043712A3 (de) | Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
| WO2002043714A3 (de) | Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
| JPS5238013A (en) | Sanitary treatment of materials used in contact with the skin | |
| FR2859901B1 (fr) | Aiguille et dispositif chirurgicaux pour le traitement de l'incontinence urinaire d'effort chez une femme, ainsi que procede de fabrication de l'aiguille | |
| IL162776A0 (en) | 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |